Total Payments
$1.6M
2024 Payments
$229,028
Companies
18
Transactions
167
Payment Breakdown by Category
Consulting$1.6M (96.6%)
Travel$55,153 (3.4%)
Food & Beverage$1,166 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.6M | 120 | 96.6% |
| Travel and Lodging | $55,153 | 20 | 3.4% |
| Food and Beverage | $1,166 | 27 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $945,599 | 79 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $578,814 | 53 | $0 (2019) |
| EMD Serono Research & Development Institute, Inc. | $53,500 | 4 | $0 (2023) |
| SANOFI US SERVICES INC. | $48,824 | 9 | $0 (2024) |
| Exelixis Inc. | $6,600 | 2 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $5,974 | 1 | $0 (2023) |
| EMD Serono, Inc. | $5,500 | 1 | $0 (2019) |
| Aries Pharmaceuticals, Inc. | $100.45 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $71.32 | 4 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $47.62 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $229,028 | 25 | Mallinckrodt Hospital Products Inc. ($200,170) |
| 2023 | $238,298 | 25 | Mallinckrodt Hospital Products Inc. ($164,329) |
| 2022 | $194,616 | 15 | Mallinckrodt Hospital Products Inc. ($186,680) |
| 2021 | $221,993 | 16 | Mallinckrodt Hospital Products Inc. ($217,793) |
| 2020 | $176,627 | 17 | Mallinckrodt Hospital Products Inc. ($176,627) |
| 2019 | $201,439 | 23 | Mallinckrodt Enterprises LLC ($195,764) |
| 2018 | $225,891 | 26 | Mallinckrodt LLC ($225,836) |
| 2017 | $157,356 | 20 | Mallinckrodt LLC ($157,214) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $17,600.00 | General |
| Category: CRITICAL CARE | ||||||
| 11/20/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $80.00 | General |
| Category: CRITICAL CARE | ||||||
| 11/20/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $73.80 | General |
| Category: CRITICAL CARE | ||||||
| 11/16/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $66.74 | General |
| Category: CRITICAL CARE | ||||||
| 10/30/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $17,600.00 | General |
| Category: CRITICAL CARE | ||||||
| 09/18/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $17,600.00 | General |
| Category: CRITICAL CARE | ||||||
| 09/18/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: CRITICAL CARE | ||||||
| 08/28/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $17,600.00 | General |
| Category: CRITICAL CARE | ||||||
| 08/14/2024 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $2,060.00 | General |
| 07/31/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $17,600.00 | General |
| Category: CRITICAL CARE | ||||||
| 07/03/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | Cash or cash equivalent | $1,752.45 | General |
| Category: CRITICAL CARE | ||||||
| 06/12/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $17,600.00 | General |
| Category: CRITICAL CARE | ||||||
| 05/15/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $17,600.00 | General |
| Category: CRITICAL CARE | ||||||
| 05/15/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | Cash or cash equivalent | $572.16 | General |
| Category: CRITICAL CARE | ||||||
| 05/08/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $17,600.00 | General |
| Category: CRITICAL CARE | ||||||
| 05/08/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $17,600.00 | General |
| Category: CRITICAL CARE | ||||||
| 05/08/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | Cash or cash equivalent | $14,726.05 | General |
| Category: CRITICAL CARE | ||||||
| 02/21/2024 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $13,841.50 | General |
| 02/21/2024 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $5,890.00 | General |
| 02/21/2024 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $5,006.50 | General |
| 02/21/2024 | SANOFI US SERVICES INC. | — | Consulting Fee | Cash or cash equivalent | $2,060.00 | General |
| 02/14/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $11,000.00 | General |
| Category: CRITICAL CARE | ||||||
| 02/14/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | Cash or cash equivalent | $412.20 | General |
| Category: CRITICAL CARE | ||||||
| 01/10/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Consulting Fee | Cash or cash equivalent | $11,000.00 | General |
| Category: CRITICAL CARE | ||||||
| 01/10/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | Cash or cash equivalent | $1,936.58 | General |
| Category: CRITICAL CARE | ||||||
About Dr. Stephen Pappas, M.D
Dr. Stephen Pappas, M.D is a Internal Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053340638.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Pappas, M.D has received a total of $1.6M in payments from pharmaceutical and medical device companies, with $229,028 received in 2024. These payments were reported across 167 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($1.6M).
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Houston, TX
- Active Since 07/03/2006
- Last Updated 02/26/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1053340638
Products in Payments
- TERLIVAZ (Drug) $364,499
- Cabometyx (Drug) $2,400
- ELEVIEW (Device) $100.45
- XIFAXAN (Drug) $71.32
- BREATHTEK (Device) $47.62
- HARMONY (Device) $33.45
- Entyvio (Biological) $24.95
- Cook Medical Instinct (Device) $22.73
- Creon (Drug) $21.45
- Mulpleta (Drug) $15.81
- CLENPIQ (Drug) $13.84
- ENTYVIO (Biological) $13.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Houston
Mohamed Othman, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Aung Naing, Md, MD
Internal Medicine — Payments: $925,146
Internal Medicine $925,146
Miguel Escobar, M.d, M.D
Internal Medicine — Payments: $924,228
Internal Medicine $924,228
Dr. Christie Ballantyne, Md, MD
Internal Medicine — Payments: $815,154
Internal Medicine $815,154
John Heymach, M.d, M.D
Internal Medicine — Payments: $786,947
Internal Medicine $786,947
Dr. Maen Abdelrahim, Md, MD
Internal Medicine — Payments: $748,784
Internal Medicine $748,784